Black Rock Inc. Ac Immune Sa Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ac Immune Sa stock. As of the latest transaction made, Black Rock Inc. holds 2,607,431 shares of ACIU stock, worth $6.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,607,431

Previous 2,541,952 2.58%

Holding current value

$6.02 Million

Previous $7.52 Million 38.26%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.29 - $4.87 $149,946 - $318,882	65,479 Added 2.58%	2,607,431 $10.4 Million
Q1 2024 May 10, 2024	BUY	$2.66 - $4.87 $329,659 - $603,548	123,932 Added 5.13%	2,541,952 $7.52 Million
Q4 2023 Feb 13, 2024	BUY	$2.46 - $5.0 $5.94 Million - $12.1 Million	2,414,002 Added 60079.69%	2,418,020 $12.1 Million
Q4 2022 Feb 13, 2023	SELL	$1.72 - $3.12 $626,037 - $1.14 Million	-363,975 Reduced 98.91%	4,018 $8,000
Q3 2022 Nov 14, 2022	SELL	$2.4 - $3.64 $24,573 - $37,269	-10,239 Reduced 2.71%	367,993 $1.16 Million
Q2 2022 Aug 12, 2022	BUY	$2.35 - $4.47 $202,003 - $384,236	85,959 Added 29.41%	378,232 $1.37 Million
Q1 2022 May 12, 2022	BUY	$3.5 - $5.16 $16,397 - $24,174	4,685 Added 1.63%	292,273 $1.17 Million
Q4 2021 Feb 10, 2022	SELL	$4.83 - $7.56 $94,875 - $148,501	-19,643 Reduced 6.39%	287,588 $1.42 Million
Q3 2021 Nov 09, 2021	SELL	$6.2 - $8.34 $255,638 - $343,874	-41,232 Reduced 11.83%	307,231 $2.06 Million
Q2 2021 Aug 11, 2021	BUY	$6.04 - $8.37 $2.1 Million - $2.92 Million	348,463 New	348,463 $2.76 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

26.7M

Call Options Held

4.8K

Put Options Held

22.2K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $193M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account